Bulk Pharmaceutical API Sources for BICILLIN C-R

Bulk Pharmaceutical API Sources for BICILLIN C-R

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		22502
ABI Chem		AC1L2KI2
ChemMol		49410474
Chembase.cn		131659

Bulk Active Pharmaceutical Ingredient (API) Sources for: BICILLIN C-R

Last updated: August 6, 2025

Introduction

BICILLIN C-R, a broad-spectrum penicillin antibiotic, comprises benzathine penicillin G and procaine penicillin G. Its formulation is used in the treatment of various bacterial infections, notably syphilis, streptococcal infections, and rheumatic fever prophylaxis. The procurement of bulk API for BICILLIN C-R is a critical step for pharmaceutical manufacturers, impacting supply chain reliability, drug quality, and regulatory compliance. This analysis explores the global landscape of API suppliers for benzathine penicillin G and procaine penicillin G, assesses their capabilities, compliance standards, and strategic considerations for sourcing.

Global API Manufacturing Landscape for BICILLIN C-R

1. Key API Components and Manufacturing Standards

BICILLIN C-R combines two APIs: benzathine penicillin G (BPG) and procaine penicillin G (PPG). Both are β-lactam antibiotics, with manufacturing complexity influenced by stringent quality, sterility, and stability standards. The APIs must adhere to cGMP regulations, ICH guidelines, and local regulatory frameworks (e.g., FDA, EMA, WHO prequalification).

2. Major API Producers

The primary API manufacturers for BICILLIN C-R align with those producing high-quality penicillin derivatives, typically situated in India, China, Europe, and North America. The following are notable suppliers responsible for the bulk procurement of these APIs:

a. India

• Shivam Pharmachem Limited: Known for producing pharmaceutical intermediates and antibiotics, including penicillin derivatives, with rigorous quality controls suitable for parenteral products.
• Strides Pharma Science Ltd.: A prominent supplier of various antibiotics, including penicillin G derivatives, with WHO-prequalified manufacturing facilities.
• Aurobindo Pharma Limited: Offers a broad spectrum of antibiotics with cGMP compliance and proven export certifications.
• Cadila Healthcare: Produces both procaine penicillin G and benzathine penicillin G with global regulatory approvals.

b. China

• North China Pharmaceutical Group Corporation (NCPC): A significant producer of antibiotics, including β-lactams, with extensive capacity and compliance standards aligned with international markets.
• Huaian Pharmaceutical Group: Supplies penicillin derivatives with emphasis on quality control and consistent supply.

c. Europe

• Degussa (now part of Evonik): Historically a supplier of pharmaceutical-grade chemicals, including penicillin G derivatives, though production has shifted over the years.
• European API producers, such as LGC Standards and Kantō Pharm, which supply high-grade APIs compliant with regulatory standards.

d. North America

• Limited direct production of bulk APIs for BICILLIN C-R. Instead, North American companies often source from European or Asian suppliers, primarily due to manufacturing cost considerations and regulatory evolution.

Supply Chain and Sourcing Strategies

3. Criteria for API Sourcing

When selecting bulk API sources for BICILLIN C-R, key factors include:

• Regulatory Compliance: cGMP certification, WHO Prequalification, FDA or EMA approvals.
• Manufacturing Capacity & Reliability: Ability to meet demand fluctuations and ensure consistent supply.
• Quality Assurance: Validation of raw material sourcing, process validation, microbial purity, endotoxin levels, and stability.
• Pricing & Lead Times: Competitive pricing without compromising quality, with assured lead times for international logistics.
• Traceability & Documentation: Robust supply chain transparency and comprehensive documentation for regulatory audits.

4. Challenges in API Procurement

• Regulatory hurdles: Ensuring API exporters meet evolving international standards.
• Supply Chain Risks: Political, environmental, or manufacturing disruptions affecting delivery.
• Quality Variability: Differing manufacturing practices leading to potential batch-to-batch variability.

Regulatory and Quality Considerations

The procurement of APIs for BICILLIN C-R must align with strict regulatory standards. Suppliers should possess:

• Valid cGMP certifications.
• Batch release approvals consistent with pharmacopeial standards (USP, EP, BP).
• Successful WHO prequalification or submission dossiers for regulatory approval in target markets.
• Clear Documentation: Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), stability data.

Vaccine and antibiotic manufacturing regulations often require suppliers to undergo rigorous audits and regular re-assessments, making partnerships with well-established, quality-certified manufacturers crucial.

Emerging Trends and Future Directions

The API sourcing landscape for BICILLIN C-R is evolving with increasing emphasis on:

• Supply Chain Resilience: Diversification of suppliers to mitigate risks.
• Manufacturing Innovation: Adoption of continuous manufacturing processes to improve API quality and process efficiency.
• Regulatory Harmonization: Enhanced global standards to streamline approval processes.
• Sustainability: Focus on environmentally responsible manufacturing practices aligned with global standards.

Conclusion

Securing reliable, high-quality bulk APIs such as benzathine penicillin G and procaine penicillin G entails strategic engagement with reputable, compliant manufacturers predominantly in India, China, and Europe. Given the critical role of API quality in the efficacy and safety profiles of BICILLIN C-R, rigorous supplier qualification processes, adherence to international standards, and continuous supply chain monitoring are imperative. The landscape reflects a shift toward greater transparency, regulatory harmonization, and supply chain robustness, aligning with global health priorities.

---

Key Takeaways

• The primary API sources for BICILLIN C-R are India and China, with established European manufacturers also serving the market.
• Regulatory compliance, manufacturing capacity, and quality assurance are critical factors for API sourcing.
• Diversifying API suppliers mitigates supply risks amid geopolitical and environmental uncertainties.
• Strategic partnerships with suppliers holding WHO prequalification and cGMP certifications ensure product consistency.
• Evolving industry standards emphasize sustainable, efficient manufacturing, and regulatory harmonization.

---

FAQs

1. What are the main APIs used in BICILLIN C-R?
BICILLIN C-R combines benzathine penicillin G and procaine penicillin G, both β-lactam antibiotics essential for its therapeutic action.

2. Which countries are leading API suppliers for BICILLIN C-R?
India and China dominate API production due to their scale, cost advantages, and regulatory compliance. European manufacturers also supply high-quality APIs, particularly for export markets.

3. What criteria should be considered when sourcing API suppliers for BICILLIN C-R?
Regulatory compliance (cGMP, prequalification), manufacturing capacity, quality assurance, supply reliability, price competitiveness, and traceability.

4. How do regulatory standards impact API sourcing?
APIs must meet strict quality, purity, and stability standards set by WHO, FDA, EMA, or local regulators. Supplier certifications and audit histories are critical for compliance and regulatory approval.

5. What trends are shaping the future of API sourcing for antibiotics like BICILLIN C-R?
Increased emphasis on supply chain resilience, manufacturing innovation, regulatory harmonization, and sustainability practices.

---

Sources

[1] World Health Organization. (2020). Prequalification of Medicines.
[2] U.S. Food and Drug Administration. (2022). API Manufacturing Guidelines.
[3] European Medicines Agency. (2021). Quality of Pharmaceutical Substances.
[4] Indian Pharmaceutical Alliance. (2022). API Manufacturing in India.
[5] China National Pharmaceutical Industry Information Center. (2022). API Production Overview.